Margaret Martin
Policy AdvisorAbout
Education
- B.A., Meredith College
Prior Experience
During her tenure as a policy advisor on the Senate HELP Committee, Margaret led negotiations for and advised on policy issues related to the FDA, including the FDA User Fee Reauthorization Act, which reauthorized the agency's medical product user fee programs through 2027; the Food and Drug Omnibus Reform Act, which included reforms to FDA's regulation of medical products; the Modernization of Cosmetics Regulation Act, which modernized FDA's authority to regulate cosmetic products; SUPPORT for Patients and Communities Act; the Animal Drug User Fee Act of 2018; and the 21st Century Cures Act.
My latest insights
Connect
Phone
+1 202 799 4153
(Work, Washington, DC)